Celcuity, Inc. (CELC)
60.46
-3.91
(-6.07%)
USD |
NASDAQ |
Nov 16, 16:00
60.46
0.00 (0.00%)
After-Hours: 18:42
Celcuity Debt to Equity Ratio : -10.20 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | -10.20 |
| June 30, 2026 | -59.02 |
| March 31, 2026 | 6.043 |
| December 31, 2025 | 3.201 |
| September 30, 2025 | 2.739 |
| June 30, 2025 | 2.240 |
| March 31, 2025 | 1.139 |
| December 31, 2024 | 0.8472 |
| September 30, 2024 | 0.6492 |
| June 30, 2024 | 0.5462 |
| March 31, 2024 | 0.2836 |
| December 31, 2023 | 0.2679 |
| September 30, 2023 | 0.3979 |
| June 30, 2023 | 0.3314 |
| March 31, 2023 | 0.2925 |
| December 31, 2022 | 0.2634 |
| September 30, 2022 | 0.352 |
| June 30, 2022 | 0.2853 |
| March 31, 2022 | 0.2443 |
| December 31, 2021 | 0.2166 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.1979 |
| June 30, 2021 | 0.5326 |
| March 31, 2021 | 0.0061 |
| December 31, 2020 | 0.0224 |
| September 30, 2020 | 0.0227 |
| June 30, 2020 | 0.0094 |
| March 31, 2020 | 0.0111 |
| December 31, 2019 | 0.0133 |
| September 30, 2019 | 0.0139 |
| June 30, 2019 | 0.0157 |
| March 31, 2019 | 0.0161 |
| December 31, 2018 | 0.001 |
| September 30, 2018 | 0.001 |
| June 30, 2018 | 0.001 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 1.517 |
| March 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Beam Therapeutics, Inc. | 0.256 |
| Vera Therapeutics, Inc. | 0.2264 |
| Tango Therapeutics, Inc. | 0.0318 |
| Sarepta Therapeutics, Inc. | 0.6888 |
| Allogene Therapeutics, Inc. | 0.196 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 726.87M |
| Total Liabilities (Quarterly) | 800.91M |
| Shareholders Equity (Quarterly) | -74.04M |
| Current Ratio | 14.62 |
| Net Debt Paydown Yield | -3.36% |